New Risk • Jun 25
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended December 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2024 fiscal period end). Shareholders have been substantially diluted in the past year (303% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (UK£1.01m market cap, or US$1.33m). Board Change • May 20
No independent directors There are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Executive Director Paul Ryan is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors. Announcement • Mar 31
Mollyroe Plc announced that it has received £0.47 million in funding Mollyroe Plc announced a private placement of zero interest convertible loan notes for gross proceeds of £470,000 on March 31, 2026. The CLNs are convertible into ordinary shares at £0.0025 per share, unless redeemed after 9 months maturity. The CLNs attract an immediate one for one warrant, exercisable at £0.0025 per share, equating to 188,000,000 ordinary shares in the event all the warrants are exercised, and valid for a period of 5 years from the date of grant. The transaction included participation from Darren Hopkins, Chief Executive Officer for £125,000; Paul Ryan, Executive Director for £35,000; and Noel Lyons, Non-Executive Director for £35,000; and other investors. 
